

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of translational fidelity (GO:0006450) | 5.39384449 |
| 2 | lysine catabolic process (GO:0006554) | 5.21131513 |
| 3 | lysine metabolic process (GO:0006553) | 5.21131513 |
| 4 | nuclear pore complex assembly (GO:0051292) | 4.95406642 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 4.89433095 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.89433095 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.83376544 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.83376544 |
| 9 | DNA strand elongation (GO:0022616) | 4.80682110 |
| 10 | glycine metabolic process (GO:0006544) | 4.75178894 |
| 11 | glyoxylate metabolic process (GO:0046487) | 4.71476173 |
| 12 | mitotic chromosome condensation (GO:0007076) | 4.62668317 |
| 13 | proline biosynthetic process (GO:0006561) | 4.55870181 |
| 14 | serine family amino acid biosynthetic process (GO:0009070) | 4.52574271 |
| 15 | formation of translation preinitiation complex (GO:0001731) | 4.47953190 |
| 16 | aromatic amino acid family catabolic process (GO:0009074) | 4.45464286 |
| 17 | nuclear pore organization (GO:0006999) | 4.45204203 |
| 18 | DNA replication initiation (GO:0006270) | 4.38423150 |
| 19 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.35522630 |
| 20 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.33224000 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.29790438 |
| 22 | serine family amino acid catabolic process (GO:0009071) | 4.24886186 |
| 23 | cysteine metabolic process (GO:0006534) | 4.24266694 |
| 24 | serine family amino acid metabolic process (GO:0009069) | 4.19108819 |
| 25 | amino-acid betaine metabolic process (GO:0006577) | 4.16099840 |
| 26 | tryptophan catabolic process (GO:0006569) | 4.13412949 |
| 27 | indole-containing compound catabolic process (GO:0042436) | 4.13412949 |
| 28 | indolalkylamine catabolic process (GO:0046218) | 4.13412949 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.12003821 |
| 30 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 4.05631894 |
| 31 | valine metabolic process (GO:0006573) | 4.05488662 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.05402777 |
| 33 | alpha-linolenic acid metabolic process (GO:0036109) | 4.04400718 |
| 34 | mitotic sister chromatid segregation (GO:0000070) | 4.02943778 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 4.00673946 |
| 36 | L-serine metabolic process (GO:0006563) | 3.92804213 |
| 37 | tryptophan metabolic process (GO:0006568) | 3.88395710 |
| 38 | bile acid biosynthetic process (GO:0006699) | 3.87526004 |
| 39 | aspartate family amino acid catabolic process (GO:0009068) | 3.83785453 |
| 40 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.81508519 |
| 41 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.77681690 |
| 42 | ethanol oxidation (GO:0006069) | 3.76811973 |
| 43 | homocysteine metabolic process (GO:0050667) | 3.75791841 |
| 44 | fatty acid beta-oxidation (GO:0006635) | 3.74738348 |
| 45 | pore complex assembly (GO:0046931) | 3.72798877 |
| 46 | acetyl-CoA metabolic process (GO:0006084) | 3.70856888 |
| 47 | mitotic nuclear envelope disassembly (GO:0007077) | 3.69948506 |
| 48 | establishment of integrated proviral latency (GO:0075713) | 3.69413624 |
| 49 | sister chromatid segregation (GO:0000819) | 3.67253117 |
| 50 | regulation of triglyceride catabolic process (GO:0010896) | 3.67151509 |
| 51 | histone arginine methylation (GO:0034969) | 3.67042631 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 3.66748836 |
| 53 | urea metabolic process (GO:0019627) | 3.65950489 |
| 54 | urea cycle (GO:0000050) | 3.65950489 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 3.65776245 |
| 56 | Golgi transport vesicle coating (GO:0048200) | 3.65776245 |
| 57 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.64911323 |
| 58 | branched-chain amino acid catabolic process (GO:0009083) | 3.63873019 |
| 59 | carnitine metabolic process (GO:0009437) | 3.63716168 |
| 60 | peptidyl-arginine methylation (GO:0018216) | 3.63313062 |
| 61 | peptidyl-arginine N-methylation (GO:0035246) | 3.63313062 |
| 62 | tricarboxylic acid cycle (GO:0006099) | 3.61428639 |
| 63 | tRNA aminoacylation for protein translation (GO:0006418) | 3.59411988 |
| 64 | DNA replication checkpoint (GO:0000076) | 3.58346141 |
| 65 | oxaloacetate metabolic process (GO:0006107) | 3.56208859 |
| 66 | ribosome assembly (GO:0042255) | 3.55674413 |
| 67 | telomere maintenance via recombination (GO:0000722) | 3.52443991 |
| 68 | ribosome biogenesis (GO:0042254) | 3.52091066 |
| 69 | tetrahydrofolate metabolic process (GO:0046653) | 3.49820784 |
| 70 | short-chain fatty acid metabolic process (GO:0046459) | 3.49662780 |
| 71 | protein complex localization (GO:0031503) | 3.47980450 |
| 72 | tRNA aminoacylation (GO:0043039) | 3.47288188 |
| 73 | amino acid activation (GO:0043038) | 3.47288188 |
| 74 | branched-chain amino acid metabolic process (GO:0009081) | 3.47111029 |
| 75 | viral mRNA export from host cell nucleus (GO:0046784) | 3.46794984 |
| 76 | nuclear envelope disassembly (GO:0051081) | 3.46501723 |
| 77 | membrane disassembly (GO:0030397) | 3.46501723 |
| 78 | negative regulation of fibrinolysis (GO:0051918) | 3.46160095 |
| 79 | ribosomal small subunit biogenesis (GO:0042274) | 3.45366574 |
| 80 | cellular amino acid catabolic process (GO:0009063) | 3.44149474 |
| 81 | fatty acid oxidation (GO:0019395) | 3.44100552 |
| 82 | tricarboxylic acid metabolic process (GO:0072350) | 3.43809414 |
| 83 | negative regulation of mRNA processing (GO:0050686) | 3.43151484 |
| 84 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.41265165 |
| 85 | nucleobase biosynthetic process (GO:0046112) | 3.38697643 |
| 86 | nitrogen cycle metabolic process (GO:0071941) | 3.38561169 |
| 87 | protein localization to chromosome, centromeric region (GO:0071459) | 3.38230504 |
| 88 | folic acid metabolic process (GO:0046655) | 3.37260011 |
| 89 | lipid oxidation (GO:0034440) | 3.34384696 |
| 90 | regulation of mitochondrial translation (GO:0070129) | 3.33980920 |
| 91 | DNA topological change (GO:0006265) | 3.33281761 |
| 92 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.32922863 |
| 93 | DNA duplex unwinding (GO:0032508) | 3.31988196 |
| 94 | fatty acid catabolic process (GO:0009062) | 3.31243024 |
| 95 | regulation of translational elongation (GO:0006448) | 3.29280676 |
| 96 | imidazole-containing compound metabolic process (GO:0052803) | 3.28598823 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 3.28504228 |
| 98 | mitotic recombination (GO:0006312) | 3.28422849 |
| 99 | maturation of SSU-rRNA (GO:0030490) | 3.28013500 |
| 100 | proline metabolic process (GO:0006560) | 3.25323248 |
| 101 | purine nucleobase biosynthetic process (GO:0009113) | 3.24799918 |
| 102 | regulation of protein activation cascade (GO:2000257) | 3.22579954 |
| 103 | one-carbon metabolic process (GO:0006730) | 3.22009728 |
| 104 | heterochromatin organization (GO:0070828) | 3.21984156 |
| 105 | IMP biosynthetic process (GO:0006188) | 3.21560131 |
| 106 | protein localization to kinetochore (GO:0034501) | 3.20117605 |
| 107 | organic acid catabolic process (GO:0016054) | 3.19461124 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.19461124 |
| 109 | complement activation, alternative pathway (GO:0006957) | 3.18162149 |
| 110 | bile acid metabolic process (GO:0008206) | 3.18066688 |
| 111 | monocarboxylic acid catabolic process (GO:0072329) | 3.17850799 |
| 112 | DNA geometric change (GO:0032392) | 3.15770856 |
| 113 | rRNA transcription (GO:0009303) | 3.12746457 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 3.12705933 |
| 115 | negative regulation of RNA splicing (GO:0033119) | 3.12028797 |
| 116 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.11230500 |
| 117 | negative regulation of mRNA metabolic process (GO:1903312) | 3.10707400 |
| 118 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10645050 |
| 119 | urate metabolic process (GO:0046415) | 3.08758669 |
| 120 | mitotic metaphase plate congression (GO:0007080) | 3.08758062 |
| 121 | aldehyde catabolic process (GO:0046185) | 3.08011181 |
| 122 | cellular protein complex localization (GO:0034629) | 3.06014304 |
| 123 | regulation of translational termination (GO:0006449) | 3.05628264 |
| 124 | chromosome condensation (GO:0030261) | 3.04484795 |
| 125 | NADH metabolic process (GO:0006734) | 3.03690786 |
| 126 | biotin metabolic process (GO:0006768) | 3.03383966 |
| 127 | regulation of fibrinolysis (GO:0051917) | 3.03304303 |
| 128 | regulation of complement activation (GO:0030449) | 3.02305155 |
| 129 | ribosomal large subunit biogenesis (GO:0042273) | 3.01803950 |
| 130 | aspartate family amino acid metabolic process (GO:0009066) | 3.01704056 |
| 131 | cellular modified amino acid catabolic process (GO:0042219) | 3.01463131 |
| 132 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.01305114 |
| 133 | folic acid-containing compound metabolic process (GO:0006760) | 2.99776306 |
| 134 | DNA unwinding involved in DNA replication (GO:0006268) | 2.98810300 |
| 135 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.98793465 |
| 136 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.98336434 |
| 137 | drug transmembrane transport (GO:0006855) | 2.97445192 |
| 138 | IMP metabolic process (GO:0046040) | 2.97227357 |
| 139 | fatty acid transmembrane transport (GO:1902001) | 2.96972112 |
| 140 | dicarboxylic acid metabolic process (GO:0043648) | 2.96954532 |
| 141 | DNA conformation change (GO:0071103) | 2.96543035 |
| 142 | protein carboxylation (GO:0018214) | 2.96410870 |
| 143 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.96410870 |
| 144 | protein-DNA complex disassembly (GO:0032986) | 2.95326483 |
| 145 | nucleosome disassembly (GO:0006337) | 2.95326483 |
| 146 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.94468602 |
| 147 | negative regulation of cholesterol transport (GO:0032375) | 2.93106628 |
| 148 | negative regulation of sterol transport (GO:0032372) | 2.93106628 |
| 149 | establishment of viral latency (GO:0019043) | 2.91700146 |
| 150 | regulation of mitotic spindle organization (GO:0060236) | 2.90655336 |
| 151 | glutamate metabolic process (GO:0006536) | 2.90609168 |
| 152 | nuclear envelope organization (GO:0006998) | 2.89076645 |
| 153 | oxidative phosphorylation (GO:0006119) | 2.89027925 |
| 154 | triglyceride homeostasis (GO:0070328) | 2.88692012 |
| 155 | acylglycerol homeostasis (GO:0055090) | 2.88692012 |
| 156 | benzene-containing compound metabolic process (GO:0042537) | 2.87407658 |
| 157 | succinate metabolic process (GO:0006105) | 2.87341530 |
| 158 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.86640369 |
| 159 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.85230912 |
| 160 | carnitine shuttle (GO:0006853) | 2.85060418 |
| 161 | telomere maintenance via telomere lengthening (GO:0010833) | 2.84363875 |
| 162 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.84292574 |
| 163 | tyrosine metabolic process (GO:0006570) | 2.82391673 |
| 164 | coenzyme catabolic process (GO:0009109) | 2.82377986 |
| 165 | regulation of RNA export from nucleus (GO:0046831) | 2.82104101 |
| 166 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.80955874 |
| 167 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.80801343 |
| 168 | mitotic sister chromatid cohesion (GO:0007064) | 2.79540158 |
| 169 | indolalkylamine metabolic process (GO:0006586) | 2.79298969 |
| 170 | sulfur amino acid metabolic process (GO:0000096) | 2.79292118 |
| 171 | plasma lipoprotein particle clearance (GO:0034381) | 2.78227998 |
| 172 | protein maturation by protein folding (GO:0022417) | 2.77685561 |
| 173 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.77357251 |
| 174 | glycolytic process (GO:0006096) | 2.76426331 |
| 175 | gluconeogenesis (GO:0006094) | 2.75826096 |
| 176 | base-excision repair (GO:0006284) | 2.74745281 |
| 177 | positive regulation of chromosome segregation (GO:0051984) | 2.73948496 |
| 178 | mitochondrial RNA metabolic process (GO:0000959) | 2.73726425 |
| 179 | pentose-phosphate shunt (GO:0006098) | 2.73690220 |
| 180 | transcription from mitochondrial promoter (GO:0006390) | 2.72555031 |
| 181 | mitochondrial fusion (GO:0008053) | 2.71774174 |
| 182 | protein export from nucleus (GO:0006611) | 2.71260374 |
| 183 | non-recombinational repair (GO:0000726) | 2.69639847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.16983635 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.67652886 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.24274732 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.64401763 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.56040305 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.47405526 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.29280379 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.96910483 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.89304729 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.59643523 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56485274 |
| 12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.31445529 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.31066171 |
| 14 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24614140 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.22680056 |
| 16 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.13038282 |
| 17 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12578494 |
| 18 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.10475478 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.02413763 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.01239231 |
| 21 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.01214030 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.95871375 |
| 23 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.91230385 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.90765256 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.90431889 |
| 26 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.85593453 |
| 27 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.81737812 |
| 28 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.76878628 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73412509 |
| 30 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71211787 |
| 31 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.70757776 |
| 32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68960671 |
| 33 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.66872885 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.66486165 |
| 35 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.60937496 |
| 36 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60058835 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.56429969 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.52462558 |
| 39 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49546083 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.49326850 |
| 41 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.46852867 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.46698719 |
| 43 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.46176539 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43766492 |
| 45 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40869806 |
| 46 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39539230 |
| 47 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38588766 |
| 48 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.38031369 |
| 49 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.37805327 |
| 50 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.37567957 |
| 51 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35664069 |
| 52 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.35544382 |
| 53 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.34960065 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.33394172 |
| 55 | MYC_22102868_ChIP-Seq_BL_Human | 1.33315494 |
| 56 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.33195969 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.29658652 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28964087 |
| 59 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.23712148 |
| 60 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21466284 |
| 61 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21451634 |
| 62 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.20999688 |
| 63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.20224168 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20140564 |
| 65 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.19207385 |
| 66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18743195 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.18086204 |
| 68 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.17925786 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.17863383 |
| 70 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17160220 |
| 71 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.16461068 |
| 72 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.15687784 |
| 73 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.15531484 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14534864 |
| 75 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.14347904 |
| 76 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.13551643 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12010130 |
| 78 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11250457 |
| 79 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.09626887 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.09528512 |
| 81 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08757773 |
| 82 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08178512 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07174357 |
| 84 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.06536187 |
| 85 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06147922 |
| 86 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06006534 |
| 87 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05517531 |
| 88 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.05392791 |
| 89 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.04379860 |
| 90 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03681470 |
| 91 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03147883 |
| 92 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.02834427 |
| 93 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02543526 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02210795 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02073296 |
| 96 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.98832213 |
| 97 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98453486 |
| 98 | P68_20966046_ChIP-Seq_HELA_Human | 0.97801898 |
| 99 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97330241 |
| 100 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.96323413 |
| 101 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.96097641 |
| 102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95980407 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95034417 |
| 104 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94178503 |
| 105 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94111699 |
| 106 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94096917 |
| 107 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93951929 |
| 108 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93411809 |
| 109 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92504095 |
| 110 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.91531669 |
| 111 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.90684114 |
| 112 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90021614 |
| 113 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89834601 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89095425 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88560523 |
| 116 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.88076825 |
| 117 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.87656556 |
| 118 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.86213545 |
| 119 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.85261894 |
| 120 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.84529831 |
| 121 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.84277892 |
| 122 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.82013078 |
| 123 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.81556771 |
| 124 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79079364 |
| 125 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.78731349 |
| 126 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.78695793 |
| 127 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76743067 |
| 128 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.75746531 |
| 129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.74471089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.82191699 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.77749903 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 5.04178899 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.56328160 |
| 5 | MP0005365_abnormal_bile_salt | 4.43693020 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.41929390 |
| 7 | MP0004233_abnormal_muscle_weight | 2.68271854 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.60082396 |
| 9 | MP0005332_abnormal_amino_acid | 2.57726611 |
| 10 | MP0003252_abnormal_bile_duct | 2.51341124 |
| 11 | MP0009840_abnormal_foam_cell | 2.22257142 |
| 12 | MP0010234_abnormal_vibrissa_follicle | 2.10879910 |
| 13 | MP0005083_abnormal_biliary_tract | 2.07869613 |
| 14 | MP0006036_abnormal_mitochondrial_physio | 2.07571414 |
| 15 | MP0003186_abnormal_redox_activity | 2.04734781 |
| 16 | MP0010094_abnormal_chromosome_stability | 1.93582687 |
| 17 | MP0003693_abnormal_embryo_hatching | 1.88732999 |
| 18 | MP0005319_abnormal_enzyme/_coenzyme | 1.84390078 |
| 19 | MP0001764_abnormal_homeostasis | 1.83679631 |
| 20 | MP0002877_abnormal_melanocyte_morpholog | 1.82139844 |
| 21 | MP0000609_abnormal_liver_physiology | 1.81667959 |
| 22 | MP0005670_abnormal_white_adipose | 1.80462327 |
| 23 | MP0001666_abnormal_nutrient_absorption | 1.76332350 |
| 24 | MP0000537_abnormal_urethra_morphology | 1.74797215 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 1.74448892 |
| 26 | MP0003195_calcinosis | 1.70424390 |
| 27 | MP0005076_abnormal_cell_differentiation | 1.69702589 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.67867409 |
| 29 | MP0010030_abnormal_orbit_morphology | 1.63056407 |
| 30 | MP0003123_paternal_imprinting | 1.60361919 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.59205049 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.58586232 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.57001938 |
| 34 | MP0000566_synostosis | 1.56483034 |
| 35 | MP0002118_abnormal_lipid_homeostasis | 1.55387238 |
| 36 | MP0005501_abnormal_skin_physiology | 1.53153125 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47296520 |
| 38 | MP0009643_abnormal_urine_homeostasis | 1.45081638 |
| 39 | MP0000313_abnormal_cell_death | 1.43597899 |
| 40 | MP0002396_abnormal_hematopoietic_system | 1.42253447 |
| 41 | MP0003077_abnormal_cell_cycle | 1.42200240 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.41227965 |
| 43 | MP0002796_impaired_skin_barrier | 1.40644323 |
| 44 | MP0009697_abnormal_copulation | 1.40578476 |
| 45 | MP0002085_abnormal_embryonic_tissue | 1.39869249 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.39105278 |
| 47 | MP0008057_abnormal_DNA_replication | 1.37454699 |
| 48 | MP0003315_abnormal_perineum_morphology | 1.36630288 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.33984358 |
| 50 | MP0000598_abnormal_liver_morphology | 1.32836801 |
| 51 | MP0002084_abnormal_developmental_patter | 1.31707045 |
| 52 | MP0005266_abnormal_metabolism | 1.30530980 |
| 53 | MP0004147_increased_porphyrin_level | 1.29524332 |
| 54 | MP0004858_abnormal_nervous_system | 1.28782111 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.28383428 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.27463881 |
| 57 | MP0000747_muscle_weakness | 1.25734786 |
| 58 | MP0004084_abnormal_cardiac_muscle | 1.22786121 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.21946078 |
| 60 | MP0000751_myopathy | 1.21575039 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.21130642 |
| 62 | MP0002249_abnormal_larynx_morphology | 1.21074687 |
| 63 | MP0004130_abnormal_muscle_cell | 1.19877564 |
| 64 | MP0003646_muscle_fatigue | 1.19192753 |
| 65 | MP0001849_ear_inflammation | 1.16392103 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.14368288 |
| 67 | MP0008058_abnormal_DNA_repair | 1.11190316 |
| 68 | MP0001730_embryonic_growth_arrest | 1.10243371 |
| 69 | MP0002269_muscular_atrophy | 1.09426825 |
| 70 | MP0005330_cardiomyopathy | 1.05007759 |
| 71 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02323349 |
| 72 | MP0001727_abnormal_embryo_implantation | 1.01929466 |
| 73 | MP0002697_abnormal_eye_size | 0.99943199 |
| 74 | MP0005623_abnormal_meninges_morphology | 0.99605633 |
| 75 | MP0002138_abnormal_hepatobiliary_system | 0.98731515 |
| 76 | MP0000759_abnormal_skeletal_muscle | 0.97313521 |
| 77 | MP0005376_homeostasis/metabolism_phenot | 0.96625629 |
| 78 | MP0008260_abnormal_autophagy | 0.94738061 |
| 79 | MP0009763_increased_sensitivity_to | 0.93423076 |
| 80 | MP0008007_abnormal_cellular_replicative | 0.92662805 |
| 81 | MP0000579_abnormal_nail_morphology | 0.92052134 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.91219900 |
| 83 | MP0005636_abnormal_mineral_homeostasis | 0.90099756 |
| 84 | MP0005384_cellular_phenotype | 0.88036404 |
| 85 | MP0003941_abnormal_skin_development | 0.84885632 |
| 86 | MP0003937_abnormal_limbs/digits/tail_de | 0.83592420 |
| 87 | MP0005375_adipose_tissue_phenotype | 0.82478514 |
| 88 | MP0000749_muscle_degeneration | 0.81806744 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.81764850 |
| 90 | MP0003942_abnormal_urinary_system | 0.81563081 |
| 91 | MP0005621_abnormal_cell_physiology | 0.79430745 |
| 92 | MP0001529_abnormal_vocalization | 0.79223096 |
| 93 | MP0004036_abnormal_muscle_relaxation | 0.79004681 |
| 94 | MP0009672_abnormal_birth_weight | 0.78439134 |
| 95 | MP0002970_abnormal_white_adipose | 0.76886314 |
| 96 | MP0003984_embryonic_growth_retardation | 0.76871448 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.76038956 |
| 98 | MP0002111_abnormal_tail_morphology | 0.75838037 |
| 99 | MP0002088_abnormal_embryonic_growth/wei | 0.75565570 |
| 100 | MP0009703_decreased_birth_body | 0.75066387 |
| 101 | MP0003385_abnormal_body_wall | 0.74964813 |
| 102 | MP0002971_abnormal_brown_adipose | 0.74761432 |
| 103 | MP0010307_abnormal_tumor_latency | 0.74605097 |
| 104 | MP0002210_abnormal_sex_determination | 0.74497852 |
| 105 | MP0001672_abnormal_embryogenesis/_devel | 0.74390115 |
| 106 | MP0005380_embryogenesis_phenotype | 0.74390115 |
| 107 | MP0001348_abnormal_lacrimal_gland | 0.73871757 |
| 108 | MP0005647_abnormal_sex_gland | 0.73767050 |
| 109 | MP0001756_abnormal_urination | 0.73175346 |
| 110 | MP0004782_abnormal_surfactant_physiolog | 0.72881519 |
| 111 | MP0003868_abnormal_feces_composition | 0.72505620 |
| 112 | MP0008469_abnormal_protein_level | 0.72315970 |
| 113 | MP0000733_abnormal_muscle_development | 0.72294500 |
| 114 | MP0001661_extended_life_span | 0.72104484 |
| 115 | MP0002163_abnormal_gland_morphology | 0.71816494 |
| 116 | MP0000358_abnormal_cell_content/ | 0.71530975 |
| 117 | MP0003566_abnormal_cell_adhesion | 0.70927621 |
| 118 | MP0002098_abnormal_vibrissa_morphology | 0.70738976 |
| 119 | MP0003861_abnormal_nervous_system | 0.70449429 |
| 120 | MP0010630_abnormal_cardiac_muscle | 0.70347109 |
| 121 | MP0002080_prenatal_lethality | 0.69772668 |
| 122 | MP0003718_maternal_effect | 0.69246886 |
| 123 | MP0002019_abnormal_tumor_incidence | 0.69191424 |
| 124 | MP0005397_hematopoietic_system_phenotyp | 0.68594503 |
| 125 | MP0001545_abnormal_hematopoietic_system | 0.68594503 |
| 126 | MP0000350_abnormal_cell_proliferation | 0.68000799 |
| 127 | MP0005451_abnormal_body_composition | 0.67991439 |
| 128 | MP0001853_heart_inflammation | 0.67765161 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.67384633 |
| 130 | MP0000467_abnormal_esophagus_morphology | 0.67360125 |
| 131 | MP0009642_abnormal_blood_homeostasis | 0.67296103 |
| 132 | MP0004087_abnormal_muscle_fiber | 0.67273328 |
| 133 | MP0003115_abnormal_respiratory_system | 0.66906284 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.66108063 |
| 135 | MP0005385_cardiovascular_system_phenoty | 0.65667658 |
| 136 | MP0001544_abnormal_cardiovascular_syste | 0.65667658 |
| 137 | MP0001881_abnormal_mammary_gland | 0.65167425 |
| 138 | MP0003786_premature_aging | 0.64922260 |
| 139 | MP0004197_abnormal_fetal_growth/weight/ | 0.64868715 |
| 140 | MP0008932_abnormal_embryonic_tissue | 0.63787810 |
| 141 | MP0002086_abnormal_extraembryonic_tissu | 0.63520262 |
| 142 | MP0000762_abnormal_tongue_morphology | 0.63187419 |
| 143 | MP0002092_abnormal_eye_morphology | 0.62780010 |
| 144 | MP0005023_abnormal_wound_healing | 0.62739056 |
| 145 | MP0001697_abnormal_embryo_size | 0.62168767 |
| 146 | MP0008995_early_reproductive_senescence | 0.62143072 |
| 147 | MP0004185_abnormal_adipocyte_glucose | 0.61756915 |
| 148 | MP0006054_spinal_hemorrhage | 0.61483865 |
| 149 | MP0005408_hypopigmentation | 0.60973993 |
| 150 | MP0009053_abnormal_anal_canal | 0.60517491 |
| 151 | MP0009765_abnormal_xenobiotic_induced | 0.59334704 |
| 152 | MP0002078_abnormal_glucose_homeostasis | 0.59157817 |
| 153 | MP0000490_abnormal_crypts_of | 0.57881281 |
| 154 | MP0002132_abnormal_respiratory_system | 0.57056940 |
| 155 | MP0005334_abnormal_fat_pad | 0.56143072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.03460023 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.79790331 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 4.77610090 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.73493767 |
| 5 | Hyperglycinuria (HP:0003108) | 4.72083735 |
| 6 | Hyperammonemia (HP:0001987) | 4.68380261 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.40841449 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.40841449 |
| 9 | Deep venous thrombosis (HP:0002625) | 4.30888165 |
| 10 | Hyperglycinemia (HP:0002154) | 4.30550824 |
| 11 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.18564835 |
| 12 | Hypoglycemic coma (HP:0001325) | 4.13748999 |
| 13 | Ketosis (HP:0001946) | 4.06552075 |
| 14 | Xanthomatosis (HP:0000991) | 4.02975858 |
| 15 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.78517275 |
| 16 | Progressive muscle weakness (HP:0003323) | 3.73076220 |
| 17 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.69257740 |
| 18 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.68922996 |
| 19 | Dicarboxylic aciduria (HP:0003215) | 3.68922996 |
| 20 | Microvesicular hepatic steatosis (HP:0001414) | 3.59478273 |
| 21 | Chromsome breakage (HP:0040012) | 3.57715324 |
| 22 | Hypolipoproteinemia (HP:0010981) | 3.57445013 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45585407 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.44737902 |
| 25 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.36674977 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.32666387 |
| 27 | Abnormality of serum amino acid levels (HP:0003112) | 3.27256267 |
| 28 | Ketoacidosis (HP:0001993) | 3.27074019 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.26046265 |
| 30 | Prolonged partial thromboplastin time (HP:0003645) | 3.25048961 |
| 31 | Rhabdomyolysis (HP:0003201) | 3.23923585 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.23583266 |
| 33 | Generalized aminoaciduria (HP:0002909) | 3.21570837 |
| 34 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.21235073 |
| 35 | Hyperacusis (HP:0010780) | 3.14411327 |
| 36 | Myoglobinuria (HP:0002913) | 3.11920869 |
| 37 | Cerebral edema (HP:0002181) | 3.04990921 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.02784997 |
| 39 | Insomnia (HP:0100785) | 3.02023114 |
| 40 | Lethargy (HP:0001254) | 3.00308209 |
| 41 | Hepatic necrosis (HP:0002605) | 2.99832099 |
| 42 | Hypoalphalipoproteinemia (HP:0003233) | 2.94612071 |
| 43 | Hyperbilirubinemia (HP:0002904) | 2.93954715 |
| 44 | Complement deficiency (HP:0004431) | 2.90693013 |
| 45 | Metabolic acidosis (HP:0001942) | 2.87850471 |
| 46 | Nausea (HP:0002018) | 2.86193183 |
| 47 | Increased nuchal translucency (HP:0010880) | 2.85669124 |
| 48 | Spastic diplegia (HP:0001264) | 2.83996399 |
| 49 | Trismus (HP:0000211) | 2.80632032 |
| 50 | Delayed CNS myelination (HP:0002188) | 2.78572432 |
| 51 | Reticulocytopenia (HP:0001896) | 2.71816336 |
| 52 | Proximal tubulopathy (HP:0000114) | 2.70913854 |
| 53 | Fat malabsorption (HP:0002630) | 2.70857956 |
| 54 | Gout (HP:0001997) | 2.68028759 |
| 55 | Epidermoid cyst (HP:0200040) | 2.66579262 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.64918858 |
| 57 | Abnormality of reticulocytes (HP:0004312) | 2.60713853 |
| 58 | Abnormality of the common coagulation pathway (HP:0010990) | 2.57392265 |
| 59 | Birth length less than 3rd percentile (HP:0003561) | 2.57137110 |
| 60 | Abnormality of glycolysis (HP:0004366) | 2.54279678 |
| 61 | Increased serum pyruvate (HP:0003542) | 2.54279678 |
| 62 | Joint hemorrhage (HP:0005261) | 2.46382354 |
| 63 | Selective tooth agenesis (HP:0001592) | 2.45542357 |
| 64 | Proximal placement of thumb (HP:0009623) | 2.43700995 |
| 65 | Progressive external ophthalmoplegia (HP:0000590) | 2.42122516 |
| 66 | Hepatocellular carcinoma (HP:0001402) | 2.40476916 |
| 67 | Multiple enchondromatosis (HP:0005701) | 2.40178616 |
| 68 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.38014591 |
| 69 | Septate vagina (HP:0001153) | 2.37743751 |
| 70 | Vomiting (HP:0002013) | 2.37005834 |
| 71 | Dysmetric saccades (HP:0000641) | 2.36791428 |
| 72 | Oral leukoplakia (HP:0002745) | 2.34476920 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.31398241 |
| 74 | Renal cortical cysts (HP:0000803) | 2.31287083 |
| 75 | Myopathic facies (HP:0002058) | 2.30365823 |
| 76 | Deviation of the thumb (HP:0009603) | 2.30297948 |
| 77 | Increased muscle lipid content (HP:0009058) | 2.29543629 |
| 78 | Ragged-red muscle fibers (HP:0003200) | 2.28752722 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.25393754 |
| 80 | Hypercholesterolemia (HP:0003124) | 2.23854944 |
| 81 | Increased purine levels (HP:0004368) | 2.22761667 |
| 82 | Hyperuricemia (HP:0002149) | 2.22761667 |
| 83 | Acute encephalopathy (HP:0006846) | 2.21802693 |
| 84 | Cholelithiasis (HP:0001081) | 2.21342168 |
| 85 | Truncus arteriosus (HP:0001660) | 2.18997893 |
| 86 | Lactic acidosis (HP:0003128) | 2.16456133 |
| 87 | Abnormality of complement system (HP:0005339) | 2.14215445 |
| 88 | Broad distal phalanx of finger (HP:0009836) | 2.13597220 |
| 89 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.13342850 |
| 90 | Overriding aorta (HP:0002623) | 2.12787677 |
| 91 | Calcaneovalgus deformity (HP:0001848) | 2.12566363 |
| 92 | Achilles tendon contracture (HP:0001771) | 2.10044596 |
| 93 | Steatorrhea (HP:0002570) | 2.09372744 |
| 94 | Abnormal cartilage morphology (HP:0002763) | 2.07574740 |
| 95 | Abnormal number of erythroid precursors (HP:0012131) | 2.07319318 |
| 96 | Increased serum lactate (HP:0002151) | 2.07212069 |
| 97 | Abnormality of the calcaneus (HP:0008364) | 2.05826595 |
| 98 | Exercise-induced muscle cramps (HP:0003710) | 2.05707943 |
| 99 | Abnormal gallbladder morphology (HP:0012437) | 2.05649912 |
| 100 | Abnormality of cochlea (HP:0000375) | 2.05211336 |
| 101 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.04618605 |
| 102 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.04618605 |
| 103 | Abnormality of the preputium (HP:0100587) | 2.04527493 |
| 104 | Increased connective tissue (HP:0009025) | 2.04440516 |
| 105 | Squamous cell carcinoma (HP:0002860) | 2.01961680 |
| 106 | Testicular atrophy (HP:0000029) | 2.00866970 |
| 107 | Overlapping toe (HP:0001845) | 1.99124999 |
| 108 | Limb hypertonia (HP:0002509) | 1.97715475 |
| 109 | Hypertriglyceridemia (HP:0002155) | 1.97304777 |
| 110 | Cortical dysplasia (HP:0002539) | 1.97272728 |
| 111 | Neonatal onset (HP:0003623) | 1.96719434 |
| 112 | Late onset (HP:0003584) | 1.96031497 |
| 113 | Glycosuria (HP:0003076) | 1.95714151 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 1.95714151 |
| 115 | Opisthotonus (HP:0002179) | 1.93862012 |
| 116 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.93469422 |
| 117 | Methylmalonic aciduria (HP:0012120) | 1.92589966 |
| 118 | Elfin facies (HP:0004428) | 1.91768665 |
| 119 | CNS demyelination (HP:0007305) | 1.90729612 |
| 120 | Deformed tarsal bones (HP:0008119) | 1.90440037 |
| 121 | Abnormality of the gallbladder (HP:0005264) | 1.90123677 |
| 122 | High anterior hairline (HP:0009890) | 1.89068787 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 1.86708584 |
| 124 | Facial cleft (HP:0002006) | 1.85985750 |
| 125 | Cholecystitis (HP:0001082) | 1.85239447 |
| 126 | Abnormal gallbladder physiology (HP:0012438) | 1.85239447 |
| 127 | Elevated hepatic transaminases (HP:0002910) | 1.84316460 |
| 128 | Pancreatitis (HP:0001733) | 1.82450185 |
| 129 | Megaloblastic anemia (HP:0001889) | 1.82145609 |
| 130 | Ulnar bowing (HP:0003031) | 1.81603270 |
| 131 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.81459315 |
| 132 | Microglossia (HP:0000171) | 1.80423366 |
| 133 | Atresia of the external auditory canal (HP:0000413) | 1.79917772 |
| 134 | Abnormality of iron homeostasis (HP:0011031) | 1.79896720 |
| 135 | Increased CSF lactate (HP:0002490) | 1.79802498 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79739389 |
| 137 | Abnormality of the umbilical cord (HP:0010881) | 1.79577588 |
| 138 | Poikilocytosis (HP:0004447) | 1.78645213 |
| 139 | Brushfield spots (HP:0001088) | 1.77865756 |
| 140 | Skin nodule (HP:0200036) | 1.76518647 |
| 141 | Reticulocytosis (HP:0001923) | 1.76401579 |
| 142 | Distal lower limb amyotrophy (HP:0008944) | 1.75452421 |
| 143 | Premature ovarian failure (HP:0008209) | 1.75014665 |
| 144 | Glossoptosis (HP:0000162) | 1.74628903 |
| 145 | Unilateral renal agenesis (HP:0000122) | 1.74208536 |
| 146 | Horseshoe kidney (HP:0000085) | 1.74126909 |
| 147 | Acanthocytosis (HP:0001927) | 1.73931612 |
| 148 | Long palpebral fissure (HP:0000637) | 1.73534696 |
| 149 | Abnormality of alanine metabolism (HP:0010916) | 1.73111804 |
| 150 | Hyperalaninemia (HP:0003348) | 1.73111804 |
| 151 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73111804 |
| 152 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72694628 |
| 153 | Secondary amenorrhea (HP:0000869) | 1.71079242 |
| 154 | Urethral obstruction (HP:0000796) | 1.70859594 |
| 155 | Sparse lateral eyebrow (HP:0005338) | 1.70805617 |
| 156 | Exercise-induced myalgia (HP:0003738) | 1.70787696 |
| 157 | Renal duplication (HP:0000075) | 1.69694557 |
| 158 | Patellar dislocation (HP:0002999) | 1.67510597 |
| 159 | Premature skin wrinkling (HP:0100678) | 1.65136645 |
| 160 | Meckel diverticulum (HP:0002245) | 1.64509003 |
| 161 | Self-mutilation (HP:0000742) | 1.63622937 |
| 162 | Choanal atresia (HP:0000453) | 1.63469950 |
| 163 | Preauricular skin tag (HP:0000384) | 1.62789025 |
| 164 | Hypoparathyroidism (HP:0000829) | 1.61867292 |
| 165 | Hyperthyroidism (HP:0000836) | 1.61084459 |
| 166 | Pointed chin (HP:0000307) | 1.60761912 |
| 167 | Upper limb amyotrophy (HP:0009129) | 1.60655050 |
| 168 | Distal upper limb amyotrophy (HP:0007149) | 1.60655050 |
| 169 | Ankyloglossia (HP:0010296) | 1.60575197 |
| 170 | Macrocytic anemia (HP:0001972) | 1.60527520 |
| 171 | Breast hypoplasia (HP:0003187) | 1.60121285 |
| 172 | Upper limb muscle weakness (HP:0003484) | 1.59987360 |
| 173 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.57989836 |
| 174 | Absent epiphyses (HP:0010577) | 1.57989836 |
| 175 | Pseudobulbar signs (HP:0002200) | 1.57734351 |
| 176 | Abnormality of the salivary glands (HP:0010286) | 1.57642478 |
| 177 | Orthostatic hypotension (HP:0001278) | 1.56946227 |
| 178 | Breech presentation (HP:0001623) | 1.56306020 |
| 179 | Abnormal number of incisors (HP:0011064) | 1.55245939 |
| 180 | Exercise intolerance (HP:0003546) | 1.55225792 |
| 181 | Rough bone trabeculation (HP:0100670) | 1.54541967 |
| 182 | Abnormality of the tricuspid valve (HP:0001702) | 1.54472334 |
| 183 | Abnormality of the carotid arteries (HP:0005344) | 1.53566636 |
| 184 | Abnormality of the ileum (HP:0001549) | 1.53065893 |
| 185 | Cafe-au-lait spot (HP:0000957) | 1.52314700 |
| 186 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.51897438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.34712543 |
| 2 | NEK1 | 3.59538857 |
| 3 | SMG1 | 3.56896476 |
| 4 | PKN2 | 3.01102479 |
| 5 | BUB1 | 2.71641718 |
| 6 | PDK3 | 2.60818177 |
| 7 | PDK4 | 2.60818177 |
| 8 | WEE1 | 2.55162253 |
| 9 | FLT3 | 2.51481552 |
| 10 | CDC7 | 2.38247606 |
| 11 | EIF2AK1 | 2.34553273 |
| 12 | TRIB3 | 2.17607662 |
| 13 | MAP2K3 | 2.12586470 |
| 14 | IRAK3 | 2.04934773 |
| 15 | VRK2 | 1.98512647 |
| 16 | TSSK6 | 1.96670287 |
| 17 | NME2 | 1.96522921 |
| 18 | EEF2K | 1.85696418 |
| 19 | PBK | 1.78707713 |
| 20 | ERN1 | 1.69460240 |
| 21 | PIK3CG | 1.67760216 |
| 22 | FGFR4 | 1.66069442 |
| 23 | NME1 | 1.61423704 |
| 24 | MST1R | 1.57402180 |
| 25 | TTK | 1.57346744 |
| 26 | NEK2 | 1.56320623 |
| 27 | RPS6KB2 | 1.55867094 |
| 28 | SIK1 | 1.51721603 |
| 29 | TTN | 1.50643883 |
| 30 | CDK4 | 1.43126537 |
| 31 | MAP3K10 | 1.36762083 |
| 32 | PDK2 | 1.34524500 |
| 33 | TGFBR1 | 1.26442602 |
| 34 | MAPK11 | 1.23885257 |
| 35 | KDR | 1.23656209 |
| 36 | EIF2AK3 | 1.21961737 |
| 37 | PASK | 1.21805859 |
| 38 | NEK9 | 1.18877449 |
| 39 | ARAF | 1.18439160 |
| 40 | ACVR1B | 1.17933884 |
| 41 | SCYL2 | 1.15835896 |
| 42 | ATR | 1.14973920 |
| 43 | MAP4K1 | 1.12033589 |
| 44 | MAP3K3 | 1.06971717 |
| 45 | BRAF | 1.06704685 |
| 46 | AURKB | 1.05969073 |
| 47 | PLK1 | 1.05702163 |
| 48 | STK4 | 1.05119826 |
| 49 | MAP3K8 | 1.03355833 |
| 50 | CDK7 | 1.02240937 |
| 51 | CDK8 | 1.01620825 |
| 52 | BRSK2 | 1.01137129 |
| 53 | OBSCN | 1.00023296 |
| 54 | PRPF4B | 0.99768401 |
| 55 | CDK12 | 0.99743506 |
| 56 | STK16 | 0.98757464 |
| 57 | LRRK2 | 0.95758106 |
| 58 | STK10 | 0.93881653 |
| 59 | TIE1 | 0.92987644 |
| 60 | MAPKAPK3 | 0.92153090 |
| 61 | SRPK1 | 0.91535563 |
| 62 | TESK2 | 0.91148249 |
| 63 | KSR2 | 0.86642163 |
| 64 | EPHA2 | 0.81569632 |
| 65 | ALK | 0.78414179 |
| 66 | CDK6 | 0.77923636 |
| 67 | CDK1 | 0.75639776 |
| 68 | LATS2 | 0.74886068 |
| 69 | MAP3K9 | 0.74786199 |
| 70 | STK38L | 0.74718213 |
| 71 | PAK4 | 0.74403130 |
| 72 | MYLK | 0.72828628 |
| 73 | PRKD3 | 0.72164632 |
| 74 | CLK1 | 0.70466350 |
| 75 | MAP2K6 | 0.68875748 |
| 76 | CCNB1 | 0.67719340 |
| 77 | KIT | 0.66086535 |
| 78 | PLK4 | 0.65472554 |
| 79 | MAP3K11 | 0.65454887 |
| 80 | RAF1 | 0.65286265 |
| 81 | DAPK1 | 0.64838056 |
| 82 | AURKA | 0.64127839 |
| 83 | PIM1 | 0.62638317 |
| 84 | MTOR | 0.62078261 |
| 85 | MET | 0.61119990 |
| 86 | GRK6 | 0.60128302 |
| 87 | CHEK1 | 0.58497163 |
| 88 | ZAK | 0.57961062 |
| 89 | CDK11A | 0.57776323 |
| 90 | VRK1 | 0.57539916 |
| 91 | BRD4 | 0.56949419 |
| 92 | PINK1 | 0.56545344 |
| 93 | TLK1 | 0.54366932 |
| 94 | CDK15 | 0.54079609 |
| 95 | CSNK2A2 | 0.53968444 |
| 96 | TYK2 | 0.53790950 |
| 97 | TAF1 | 0.53667169 |
| 98 | CAMK1D | 0.53221979 |
| 99 | RPS6KA4 | 0.53098808 |
| 100 | ABL2 | 0.52904145 |
| 101 | ERBB4 | 0.52330087 |
| 102 | MAPKAPK5 | 0.52287644 |
| 103 | PTK6 | 0.51901210 |
| 104 | CDK18 | 0.50406066 |
| 105 | BRSK1 | 0.49229739 |
| 106 | CSNK1E | 0.48863161 |
| 107 | PRKCI | 0.47822418 |
| 108 | CDK9 | 0.47710910 |
| 109 | BTK | 0.46397151 |
| 110 | CSF1R | 0.45142257 |
| 111 | CSNK2A1 | 0.44209274 |
| 112 | CDK14 | 0.43028112 |
| 113 | TAOK2 | 0.42560601 |
| 114 | PHKG1 | 0.42113892 |
| 115 | PHKG2 | 0.42113892 |
| 116 | ATM | 0.41513891 |
| 117 | ILK | 0.41262001 |
| 118 | ZAP70 | 0.41117680 |
| 119 | PAK1 | 0.40783083 |
| 120 | CDK2 | 0.40409161 |
| 121 | PRKDC | 0.40289192 |
| 122 | CHEK2 | 0.39930740 |
| 123 | AKT2 | 0.39895830 |
| 124 | EIF2AK2 | 0.39512995 |
| 125 | CSNK1G3 | 0.39035996 |
| 126 | TESK1 | 0.37659817 |
| 127 | RPS6KA6 | 0.37033476 |
| 128 | PIM2 | 0.36229928 |
| 129 | RPS6KB1 | 0.35900350 |
| 130 | RPS6KL1 | 0.35871479 |
| 131 | RPS6KC1 | 0.35871479 |
| 132 | CSNK1A1L | 0.35723502 |
| 133 | MAP3K7 | 0.34210709 |
| 134 | MAPK14 | 0.33807510 |
| 135 | FGFR1 | 0.33045732 |
| 136 | PLK3 | 0.31764080 |
| 137 | ICK | 0.30844055 |
| 138 | JAK3 | 0.30233350 |
| 139 | DYRK3 | 0.29164130 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.94666779 |
| 2 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.92924670 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.86910942 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81034091 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.65738503 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.64774472 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.63641223 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.57241767 |
| 9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48768248 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.33902530 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.14748652 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.12641227 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.10490333 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10257658 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.09298940 |
| 16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.98549301 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.96258900 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.96254853 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90893953 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.87066350 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.83715403 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.78869113 |
| 23 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75627354 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.75369609 |
| 25 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.75295164 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.73668206 |
| 27 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.71320943 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.61224357 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55489741 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47711730 |
| 31 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.47022864 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.46912165 |
| 33 | Mismatch repair_Homo sapiens_hsa03430 | 1.46590394 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.41765077 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.39731629 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38992460 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.35869457 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.33571293 |
| 39 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30714151 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.28466908 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.26263634 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25367538 |
| 43 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.24282427 |
| 44 | Sulfur relay system_Homo sapiens_hsa04122 | 1.18225639 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18126589 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15897651 |
| 47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12183218 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11915604 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10760993 |
| 50 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.09517958 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 1.08262413 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02708497 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00741740 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00570823 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.98315047 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.96516791 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 0.96311019 |
| 58 | Proteasome_Homo sapiens_hsa03050 | 0.95925895 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95501965 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95388041 |
| 61 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.93132480 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.92603685 |
| 63 | Ribosome_Homo sapiens_hsa03010 | 0.91474680 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.90149897 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.83372268 |
| 66 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.81455580 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80659806 |
| 68 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80525973 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.78914536 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77792391 |
| 71 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77376758 |
| 72 | Homologous recombination_Homo sapiens_hsa03440 | 0.75745338 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.73466792 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.70940133 |
| 75 | RNA transport_Homo sapiens_hsa03013 | 0.70624096 |
| 76 | Galactose metabolism_Homo sapiens_hsa00052 | 0.68913664 |
| 77 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67373628 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63359692 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.62835841 |
| 80 | Spliceosome_Homo sapiens_hsa03040 | 0.62728059 |
| 81 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62159505 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61383631 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.61344874 |
| 84 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60018874 |
| 85 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.59922630 |
| 86 | ABC transporters_Homo sapiens_hsa02010 | 0.59492090 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.57023273 |
| 88 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.56699866 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.54813792 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.53964573 |
| 91 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53597074 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52615248 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.50225601 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47793768 |
| 95 | Basal transcription factors_Homo sapiens_hsa03022 | 0.45075485 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.43033427 |
| 97 | Cell cycle_Homo sapiens_hsa04110 | 0.42645868 |
| 98 | Alcoholism_Homo sapiens_hsa05034 | 0.39954142 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.39743581 |
| 100 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35819223 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.34575277 |
| 102 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34436312 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33694711 |
| 104 | RNA degradation_Homo sapiens_hsa03018 | 0.33239216 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33173301 |
| 106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32863134 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.31869081 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.31345298 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30265473 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.30085264 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.29775911 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.29457420 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.28479902 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28469538 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.26848568 |
| 116 | Glioma_Homo sapiens_hsa05214 | 0.26790662 |
| 117 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26370822 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.25413842 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.24746988 |
| 120 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.24287210 |
| 121 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.23842153 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22477649 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.21772802 |
| 124 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.20554515 |
| 125 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19815859 |
| 126 | Colorectal cancer_Homo sapiens_hsa05210 | 0.19139456 |
| 127 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17761561 |
| 128 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.17549567 |
| 129 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17442500 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17118860 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.13405916 |
| 132 | Huntingtons disease_Homo sapiens_hsa05016 | 0.13376582 |
| 133 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.08490983 |
| 134 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.08243889 |

